FDA Clears 1.5T MRI Platform with Helium-Free Technology

The Food and Drug Administration (FDA) has granted 510(k) clearance for the Magnetom Flow 1.5T magnetic resonance imaging (MRI) device, which provides automated artificial intelligence (AI) workflow efficiencies, enhanced image reconstruction and significantly reduced energy consumption.

Requiring only 0.7 liters of liquid helium for cooling thanks to the device’s DryCool helium-free technology, the Magnetom Flow system was designed without a quench pipe, facilitating less installation challenges as well as reduced costs in contrast to other 1.5T MRI systems, according to Siemens Healthineers, the manufacturer of the Magnetom Flow device.

The company emphasized that the Magnetom Flow system offers a 56 percent reduction in annual energy consumption in comparison to that of previous MRI systems from Siemens Healthineers.

Siemens Healthineers noted that other features of the Magnetom Flow system include the AI-enabled Deep Resolve 2D and 3D image reconstruction, which accelerates image acquisition and enhanced image sharpness, as well as automated tools for simplifying complex MRI exams and facilitating safe exams for patients with device implants.

“The 70cm Magnetom Flow platform is an intelligent magnetic resonance scanner that exceeds clinical expectations and simplifies workflows while doubling down on our commitment to sustainability in healthcare,” said Katie Grant, the head of magnetic resonance at Siemens Healthineers North America. “This platform can help health-care institutions meet the demands of higher patient throughput in less time than previous generations of MR scanners while also lowering the total cost of ownership.”